Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer

Press/Media: Research

PeriodFeb 11 2020

Media coverage

1

Media coverage

  • TitleVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Media name/outletWFMZ-TV Online
    Country/TerritoryUnited States
    Date2/11/20
    PersonsRobert Joseph Abraham